πŸ‡ΊπŸ‡Έ FDA
Patent

US 10675325

Stable formulations of linaclotide

granted A61KA61K38/10A61K38/12

Quick answer

US patent 10675325 (Stable formulations of linaclotide) held by IRONWOOD PHARMACEUTICALS, INC. expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
IRONWOOD PHARMACEUTICALS, INC.
Grant date
Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K38/10, A61K38/12, A61K47/18, A61K9/1611